RxDoctor Payments Data

John Fenlin

Orthopaedic Surgery · Philadelphia, PANPI 1700830361

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,861,287 of the $5,861,287 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Stryker. Reporting peaked in 2022 at $1,154,803 and has fallen 50.5% since, to $571,310 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,861,287in general payments, 2019–2025

Across 56 payments — averaging $104,666 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$5.9M

What the payments were for

  • Royalty or licence$5,861,287100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)56$5,861,287

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,861,287 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →